These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 4091048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anaemia in myelofibrosis: its value in prognosis.
    Njoku OS, Lewis SM, Catovsky D, Gordon-Smith EC.
    Br J Haematol; 1983 May; 54(1):79-89. PubMed ID: 6849838
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
    Visani G, Finelli C, Castelli U, Petti MC, Ricci P, Vianelli N, Gianni L, Zuffa E, Aloe Spiriti MA, Latagliata R.
    Br J Haematol; 1990 May; 75(1):4-9. PubMed ID: 2375922
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A, Weiss M, Wiese B, Choritz H, Buhr T, Büsche G, Georgii A.
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 1-25 (OH)2 D3 in idiopathic myelofibrosis: a preliminary report.
    Petrini M, Cecconi N, Ambrogi F, Grassi B.
    Haematologica; 1987 Oct; 72(6):567-9. PubMed ID: 3126118
    [No Abstract] [Full Text] [Related]

  • 12. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
    Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S, Van Dyke D, Hanson C, Wu W, Pardanani A, Cervantes F, Passamonti F, Tefferi A.
    J Clin Oncol; 2011 Feb 01; 29(4):392-7. PubMed ID: 21149668
    [Abstract] [Full Text] [Related]

  • 13. Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis.
    Gowin K, Coakley M, Kosiorek H, Mesa R.
    Haematologica; 2016 Oct 01; 101(10):e405-e406. PubMed ID: 27354022
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of controlled daily blood loss on the haemoglobin concentration, erythrocyte count and reticulocyte count of male rats.
    Capel-Edwards K, Wheeldon JM, Mifsud CV.
    Toxicol Lett; 1981 Apr 01; 8(1-2):29-32. PubMed ID: 7245238
    [Abstract] [Full Text] [Related]

  • 17. Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.
    Strati P, Bose P, Lyle L, Gaw K, Zhou L, Pierce SA, Huynh-Lu J, Hirsch-Ginsberg CF, Bueso-Mendoza DE, Bueso-Ramos CE, Verstovsek S.
    Ann Hematol; 2017 May 01; 96(5):733-738. PubMed ID: 28247057
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.